D. Valpiani

1.3k total citations
16 papers, 966 citations indexed

About

D. Valpiani is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, D. Valpiani has authored 16 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 13 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in D. Valpiani's work include Inflammatory Bowel Disease (14 papers), Microscopic Colitis (12 papers) and Liver Diseases and Immunity (2 papers). D. Valpiani is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Microscopic Colitis (12 papers) and Liver Diseases and Immunity (2 papers). D. Valpiani collaborates with scholars based in Italy, France and Switzerland. D. Valpiani's co-authors include R. Caprilli, Piero Vernia, Gabriele Riegler, Paolo Gionchetti, Vito Annese, R. D’Incà, Giuseppe Frieri, A Torsoli, P. Paoluzi and Giovanni Corrao and has published in prestigious journals such as The American Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics and Digestive Diseases and Sciences.

In The Last Decade

D. Valpiani

16 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Valpiani Italy 12 589 414 325 249 159 16 966
Philippe Lambrette Canada 12 500 0.8× 278 0.7× 219 0.7× 173 0.7× 64 0.4× 16 748
Ágota Kovács Hungary 17 631 1.1× 491 1.2× 260 0.8× 140 0.6× 74 0.5× 43 1.0k
A.H. Steinhart Canada 11 439 0.7× 260 0.6× 229 0.7× 155 0.6× 26 0.2× 19 690
Kerri Glassner United States 7 440 0.7× 314 0.8× 188 0.6× 418 1.7× 29 0.2× 35 916
André Castro Lyra Brazil 20 324 0.6× 701 1.7× 269 0.8× 184 0.7× 39 0.2× 60 1.3k
H Sommer Germany 13 1.3k 2.2× 971 2.3× 671 2.1× 334 1.3× 98 0.6× 27 2.0k
Astrid Konrad Germany 18 506 0.9× 334 0.8× 198 0.6× 241 1.0× 28 0.2× 26 1.3k
H. Lorenz‐Meyer Germany 18 964 1.6× 734 1.8× 611 1.9× 142 0.6× 59 0.4× 51 1.5k
Ofir Har‐Noy Israel 9 499 0.8× 361 0.9× 209 0.6× 124 0.5× 38 0.2× 17 871
Maria Carla Di Paolo Italy 10 262 0.4× 138 0.3× 169 0.5× 207 0.8× 27 0.2× 23 612

Countries citing papers authored by D. Valpiani

Since Specialization
Citations

This map shows the geographic impact of D. Valpiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Valpiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Valpiani more than expected).

Fields of papers citing papers by D. Valpiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Valpiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Valpiani. The network helps show where D. Valpiani may publish in the future.

Co-authorship network of co-authors of D. Valpiani

This figure shows the co-authorship network connecting the top 25 collaborators of D. Valpiani. A scholar is included among the top collaborators of D. Valpiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Valpiani. D. Valpiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bortoli, A., N Pedersen, Dana Ďuricová, et al.. (2011). Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Alimentary Pharmacology & Therapeutics. 34(7). 724–734. 126 indexed citations
2.
Poniewierka, Elżbieta, И. Г. Бакулин, Limas Kupčinskas, et al.. (2011). Randomised clinical trial: the efficacy and safety of propionyl-l-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment. Alimentary Pharmacology & Therapeutics. 34(9). 1088–1097. 27 indexed citations
3.
Valpiani, D., et al.. (2011). P.1.139: INFLAMMATORY BOWEL DISEASE POPULATION REGISTRY: INCIDENCE AND PREVALENCE IN FORLI' DISTRICT IN ITALY (1993-2010). Digestive and Liver Disease. 43. S194–S194. 1 indexed citations
4.
Fasoli, R., D. Valpiani, Simone Saibeni, et al.. (2006). Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: Preliminary results of a prospective, multicenter study. Digestive and Liver Disease. 38. S122–S122. 17 indexed citations
5.
Riegler, Gabriele, L. Caserta, Fabiana Castiglione, et al.. (2005). Increased risk of breast cancer in first-degree relatives of Crohn's disease patientsAn IG-IBD study. Digestive and Liver Disease. 38(1). 18–23. 14 indexed citations
6.
Valpiani, D., et al.. (2004). Skip lesion of the cecum associated with proctitis: an atypical case of ulcerative colitis. Digestive and Liver Disease. 36(12). 847–851. 1 indexed citations
7.
Vernia, Piero, Vito Annese, G. Bresci, et al.. (2003). Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial. European Journal of Clinical Investigation. 33(3). 244–248. 167 indexed citations
8.
Campieri, Massimo, D. Valpiani, A. D’Arienzo, et al.. (2003). Oral beclometasone dipropionate in the treatment of extensive and left‐sided active ulcerative colitis: a multicentre randomised study. Alimentary Pharmacology & Therapeutics. 17(12). 1471–1480. 81 indexed citations
9.
Rizzello, Fernando, Paolo Gionchetti, A. D’Arienzo, et al.. (2002). Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double‐blind placebo‐controlled study. Alimentary Pharmacology & Therapeutics. 16(6). 1109–1116. 103 indexed citations
10.
Rizzello, Fernando, Paolo Gionchetti, R Galeazzi, et al.. (2001). Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: A dose-finding study. Advances in Therapy. 18(6). 261–271. 32 indexed citations
11.
Annese, Vito, Arnaldo Andreoli, Marco Astegiano, et al.. (2001). Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: a GISC* study. The American Journal of Gastroenterology. 96(10). 2939–2945. 31 indexed citations
12.
Rizzello, Fernando, Paolo Gionchetti, D. Valpiani, et al.. (2001). Oral beclomethasone dipropionate versus oral 5-aminosalicylic acid in the treatment of active ulcerative colitis: A randomised, 4 week, controlled study. Digestive and Liver Disease. 33. A31–A31. 1 indexed citations
13.
Riegler, Gabriele, M.T. Tartaglione, R. Carratù, et al.. (2000). Age-Related Clinical Severity at Diagnosis in 1705 Patients with Ulcerative Colitis. Digestive Diseases and Sciences. 45(3). 462–465. 57 indexed citations
14.
Vernia, Piero, Adriana Marcheggiano, R. Caprilli, et al.. (1995). Short‐chain fatty acid topical treatment in distal ulcerative colitis. Alimentary Pharmacology & Therapeutics. 9(3). 309–313. 188 indexed citations
15.
Tragnone, A., et al.. (1995). Dietary habits as risk factors for inflammatory bowel disease.. PubMed. 7(1). 47–51. 116 indexed citations
16.
Gasbarrini, Antonio, Gino Roberto Corazza, O Albano, et al.. (1986). A multicenter double-blind controlled trial comparing lidamidine HCl and loperamide in the symptomatic treatment of acute diarrhoea.. PubMed. 36(12). 1843–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026